182 related articles for article (PubMed ID: 35703146)
1. Tumors derived from lung cancer cells respond differently to treatment with sodium valproate (a HDAC inhibitor) in a chicken embryo chorioallantoic membrane model.
Diržiuvienė R; Šlekienė L; Palubinskienė J; Balnytė I; Lasienė K; Stakišaitis D; Valančiūtė A
Histol Histopathol; 2022 Dec; 37(12):1201-1212. PubMed ID: 35703146
[TBL] [Abstract][Full Text] [Related]
2. Sodium Valproate Inhibits Small Cell Lung Cancer Tumor Growth on the Chicken Embryo Chorioallantoic Membrane and Reduces the p53 and EZH2 Expression.
Šlekienė L; Stakišaitis D; Balnytė I; Valančiūtė A
Dose Response; 2018; 16(2):1559325818772486. PubMed ID: 29760602
[TBL] [Abstract][Full Text] [Related]
3. The Effect of Sodium Valproate on the Glioblastoma U87 Cell Line Tumor Development on the Chicken Embryo Chorioallantoic Membrane and on EZH2 and p53 Expression.
Kavaliauskaitė D; Stakišaitis D; Martinkutė J; Šlekienė L; Kazlauskas A; Balnytė I; Lesauskaitė V; Valančiūtė A
Biomed Res Int; 2017; 2017():6326053. PubMed ID: 28642877
[TBL] [Abstract][Full Text] [Related]
4. The Anti-Tumorigenic Activity of Sema3C in the Chick Embryo Chorioallantoic Membrane Model.
Valiulytė I; Curkūnavičiūtė R; Ribokaitė L; Kazlauskas A; Vaitkevičiūtė M; Skauminas K; Valančiūtė A
Int J Mol Sci; 2019 Nov; 20(22):. PubMed ID: 31726800
[TBL] [Abstract][Full Text] [Related]
5. Human Non-Small Cell Lung Cancer-Chicken Embryo Chorioallantoic Membrane Tumor Models for Experimental Cancer Treatments.
Li J; Brachtlova T; van der Meulen-Muileman IH; Kleerebezem S; Liu C; Li P; van Beusechem VW
Int J Mol Sci; 2023 Oct; 24(20):. PubMed ID: 37895104
[TBL] [Abstract][Full Text] [Related]
6. Inhibition of class I histone deacetylases in non-small cell lung cancer by honokiol leads to suppression of cancer cell growth and induction of cell death in vitro and in vivo.
Singh T; Prasad R; Katiyar SK
Epigenetics; 2013 Jan; 8(1):54-65. PubMed ID: 23221619
[TBL] [Abstract][Full Text] [Related]
7. Potentiation of anticancer effect of valproic acid, an antiepileptic agent with histone deacetylase inhibitory activity, by the cyclin-dependent kinase inhibitor P276-00 in human non-small-cell lung cancer cell lines.
Shirsath N; Rathos M; Chaudhari U; Sivaramakrishnan H; Joshi K
Lung Cancer; 2013 Nov; 82(2):214-21. PubMed ID: 24051085
[TBL] [Abstract][Full Text] [Related]
8. Effect of miR‑146a‑5p on tumor growth in NSCLC using chick chorioallantoic membrane assay and bioinformatics investigation.
Huang WT; Cen WL; He RQ; Xie Y; Zhang Y; Li P; Gan TQ; Chen G; Hu XH
Mol Med Rep; 2017 Dec; 16(6):8781-8792. PubMed ID: 28990079
[TBL] [Abstract][Full Text] [Related]
9. Sodium valproate, a histone deacetylase inhibitor, enhances the efficacy of vinorelbine-cisplatin-based chemoradiation in non-small cell lung cancer cells.
Gavrilov V; Lavrenkov K; Ariad S; Shany S
Anticancer Res; 2014 Nov; 34(11):6565-72. PubMed ID: 25368259
[TBL] [Abstract][Full Text] [Related]
10. Sodium valproate-induced congenital cardiac abnormalities in mice are associated with the inhibition of histone deacetylase.
Wu G; Nan C; Rollo JC; Huang X; Tian J
J Biomed Sci; 2010 Mar; 17(1):16. PubMed ID: 20219112
[TBL] [Abstract][Full Text] [Related]
11. Targeting the invasive phenotype of cisplatin-resistant non-small cell lung cancer cells by a novel histone deacetylase inhibitor.
Zuco V; Cassinelli G; Cossa G; Gatti L; Favini E; Tortoreto M; Cominetti D; Scanziani E; Castiglioni V; Cincinelli R; Giannini G; Zunino F; Zaffaroni N; Lanzi C; Perego P
Biochem Pharmacol; 2015 Mar; 94(2):79-90. PubMed ID: 25600908
[TBL] [Abstract][Full Text] [Related]
12. A novel histone deacetylase inhibitor exhibits antitumor activity via apoptosis induction, F-actin disruption and gene acetylation in lung cancer.
Tang YA; Wen WL; Chang JW; Wei TT; Tan YH; Salunke S; Chen CT; Chen CS; Wang YC
PLoS One; 2010 Sep; 5(9):e12417. PubMed ID: 20856855
[TBL] [Abstract][Full Text] [Related]
13. Organosulfur derivatives of the HDAC inhibitor valproic acid sensitize human lung cancer cell lines to apoptosis and to cisplatin cytotoxicity.
Tesei A; Brigliadori G; Carloni S; Fabbri F; Ulivi P; Arienti C; Sparatore A; Del Soldato P; Pasini A; Amadori D; Silvestrini R; Zoli W
J Cell Physiol; 2012 Oct; 227(10):3389-96. PubMed ID: 22212895
[TBL] [Abstract][Full Text] [Related]
14. The dual HDAC-PI3K inhibitor CUDC-907 displays single-agent activity and synergizes with PARP inhibitor olaparib in small cell lung cancer.
Ma L; Bian X; Lin W
J Exp Clin Cancer Res; 2020 Oct; 39(1):219. PubMed ID: 33069237
[TBL] [Abstract][Full Text] [Related]
15. Chicken chorioallantoic membrane angiogenesis model.
Ribatti D
Methods Mol Biol; 2012; 843():47-57. PubMed ID: 22222520
[TBL] [Abstract][Full Text] [Related]
16. The chick embryo chorioallantoic membrane as an in vivo experimental model to study human neuroblastoma.
Ribatti D; Tamma R
J Cell Physiol; 2018 Jan; 234(1):152-157. PubMed ID: 30078179
[TBL] [Abstract][Full Text] [Related]
17. Chlorin e6 - polyvinylpyrrolidone mediated photosensitization is effective against human non-small cell lung carcinoma compared to small cell lung carcinoma xenografts.
Chin WW; Heng PW; Olivo M
BMC Pharmacol; 2007 Dec; 7():15. PubMed ID: 18053148
[TBL] [Abstract][Full Text] [Related]
18. Biological evaluation of 4,5-diarylimidazoles with hydroxamic acid appendages as novel dual mode anticancer agents.
Mahal K; Schruefer S; Steinemann G; Rausch F; Schobert R; Biersack B; Höpfner M
Cancer Chemother Pharmacol; 2015 Apr; 75(4):691-700. PubMed ID: 25618416
[TBL] [Abstract][Full Text] [Related]
19. Sodium valproate potentiates staurosporine-induced apoptosis in neuroblastoma cells via Akt/survivin independently of HDAC inhibition.
Shah RD; Jagtap JC; Mruthyunjaya S; Shelke GV; Pujari R; Das G; Shastry P
J Cell Biochem; 2013 Apr; 114(4):854-63. PubMed ID: 23097134
[TBL] [Abstract][Full Text] [Related]
20. Activation of insulin-like growth factor receptor signaling mediates resistance to histone deacetylase inhibitors.
Kim JS; Lee SC; Min HY; Park KH; Hyun SY; Kwon SJ; Choi SP; Kim WY; Lee HJ; Lee HY
Cancer Lett; 2015 Jun; 361(2):197-206. PubMed ID: 25721083
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
